Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Completed 12Terminated 5Unknown 4Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 2INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 10Prostatic Neoplasms 8Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Glioblastoma 4Urinary Bladder Neoplasms 3Sarcoma 3Oropharyngeal Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Kidney Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Neoplasm Metastasis 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Glioma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Astrocytoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Anal Canal 1

Interventions

Carboplatin 103Pemetrexed 96Docetaxel 78pembrolizumab 77Cisplatin 72Paclitaxel 70Erlotinib Hydrochloride 50Gemcitabine 48Radiotherapy 42Nivolumab 35Bevacizumab 35atezolizumab 24Radiosurgery 24durvalumab 19Cyclophosphamide 17130-nm albumin-bound paclitaxel 15Vinorelbine 14Taxes 14Radiation 14Etoposide 13Ipilimumab 12Albumin-Bound Paclitaxel 12avelumab 11Drug Therapy 10Cetuximab 10spartalizumab 9Sorafenib 9trametinib 8osimertinib 8capmatinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Non-Small-Cell Lung × Radiotherapy, Intensity-Modulated × Clear all
NCT03840902 2024-01-16

M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

EMD Serono

Phase 2 Terminated
153 enrolled 13 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01912625 2023-05-06

Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
16 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02768558 2021-06-02

Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC

RTOG Foundation, Inc.

Phase 3 Terminated
20 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01822496 2019-08-05

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
59 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01411098 2015-11-04

Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

University of Washington

Phase 1 Terminated
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡